Cargando…
LHPP Inhibits the Viability, Migration, and Proliferation of PDAC Cells and Significantly Affects the Expression of SDC1 and S100p
INTRODUCTION: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with a poor response to chemotherapy and an extremely poor prognosis. Recent studies have revealed that phospholysine phosphohistidine inorganic pyrophosphate phosphatase (LHPP) can inhibit the growth of various...
Autores principales: | Xia, Zhaozhi, Zhao, Shuchao, Gao, Xin, Sun, Hongrui, Yang, Faji, Zhu, Huaqiang, Gao, Hengjun, Lu, Jun, Zhou, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278439/ https://www.ncbi.nlm.nih.gov/pubmed/37321804 http://dx.doi.org/10.1177/15330338231177807 |
Ejemplares similares
-
Short-term clinical outcomes of laparoscopic duodenum-preserving pancreatic head resection for the management of pancreatic-head cystic neoplasms
por: Xia, Zhaozhi, et al.
Publicado: (2023) -
SDC1 and ITGA2 as novel prognostic biomarkers for PDAC related to IPMN
por: Zhang, Chuan-long, et al.
Publicado: (2023) -
Prediction of small molecule drug-miRNA associations based on GNNs and CNNs
por: Niu, Zheyu, et al.
Publicado: (2023) -
LHPP suppresses proliferation, migration, and invasion and promotes apoptosis in pancreatic cancer
por: Wu, Fahong, et al.
Publicado: (2020) -
LHPP Inhibits the Proliferation and Metastasis of Renal Cell Carcinoma
por: Zhang, Xiaoting, et al.
Publicado: (2020)